New York, NY – Kyowa Hakko has announced it has completed GRAS (generally recognized as safe) self-affirmation for its dipeptide Sustamine™ L-Alanyl-L- Glutamine.
According to Yoichiro Sugimura, Kyowa Hakko USA senior director of scientific affairs and business development, Sustamine™ L-Alanyl-L-Glutamine is a "high-tech" amino acid dipeptide that promotes muscle rehydration, recovery and can be used as a source for energy refueling.
Sustamine™ L-Alanyl-L-Glutamine is produced by a novel and cost-effective patented fermentation technology. Sustamine™ is available in powder form and is water-soluble into a clear solution. It is also odorless and tasteless. The stability of Sustamine™ L-Alanyl-L-Glutamine enables it to be formulated into a variety of food and beverage and healthcare applications.
Kyowa Hakko is an international health ingredients manufacturer and world leader in the development, manufacturing and marketing of pharmaceuticals, nutraceuticals and food products. The maker of the branded ingredients Cognizin® Citicoline, Hydrafend™ Hyaluronic Acid, Lumistor® L-Hydroxyproline, Kyowa CoQ10®, Setria® Glutathione and Sustamine™ L-Alanyl-L-Glutamine, Kyowa offers manufacturers and formulators one of the industry's most extensive lines of over 50 amino acids and related compounds, including D-Amino acids and branch-chain amino acids, as well as nucleic acids, bio-products and fine chemicals.